1-11 of 11
Paul Frankel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy

Nicola R. Hardwick, Paul Frankel, Christopher Ruel, Julie Kilpatrick, Weimin Tsai, Ferdynand Kos, Teodora Kaltcheva, Lucille Leong, Robert Morgan, Vincent Chung, Raechelle Tinsley, Melissa Eng, Sharon Wilczynski, Joshua D.I. Ellenhorn, Don J. Diamond, Mihaela Cristea
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (6): 1315–1325.
https://doi.org/10.1158/1078-0432.CCR-17-2709
Published: 14 March 2018
View article titled, p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy
Open the PDF for p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients

Jana Portnow, Timothy W. Synold, Behnam Badie, Revathiswari Tirughana, Simon F. Lacey, Massimo D'Apuzzo, Marianne Z. Metz, Joseph Najbauer, Victoria Bedell, Tien Vo, Margarita Gutova, Paul Frankel, Mike Chen, Karen S. Aboody
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (12): 2951–2960.
https://doi.org/10.1158/1078-0432.CCR-16-1518
Published: 14 June 2017
View article titled, Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients
Open the PDF for Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients in another window
Includes: Supplementary data
Journal Articles

Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor–Tyrosine Kinase Inhibitors

Sumanta K. Pal, Sierra M. Li, Xiwei Wu, Hanjun Qin, Marcin Kortylewski, JoAnn Hsu, Courtney Carmichael, Paul Frankel
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (23): 5286–5293.
https://doi.org/10.1158/1078-0432.CCR-15-0724
Published: 30 November 2015
View article titled, Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor–Tyrosine Kinase Inhibitors
Open the PDF for Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor–Tyrosine Kinase Inhibitors in another window
Includes: Supplementary data
Journal Articles

Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal Origin

Ahmad A. Tarhini, Paul Frankel, Kim A. Margolin, Scott Christensen, Christopher Ruel, Janice Shipe-Spotloe, David R. Gandara, Alice Chen, John M. Kirkwood
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (20): 6574–6581.
https://doi.org/10.1158/1078-0432.CCR-11-1463
Published: 14 October 2011
View article titled, Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal Origin
Open the PDF for Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal Origin in another window
Includes: Supplementary data
Journal Articles

Total Marrow Irradiation: A New Ablative Regimen as Part of Tandem Autologous Stem Cell Transplantation for Patients with Multiple Myeloma

George Somlo, Ricardo Spielberger, Paul Frankel, Chatchada Karanes, Amrita Krishnan, Pablo Parker, Leslie Popplewell, Firoozeh Sahebi, Neil Kogut, David Snyder, An Liu, Timothy Schultheiss, Stephen Forman, Jeffrey Y. C. Wong
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (1): 174–182.
https://doi.org/10.1158/1078-0432.CCR-10-1912
Published: 04 January 2011
View article titled, Total Marrow Irradiation: A New Ablative Regimen as Part of Tandem Autologous Stem Cell Transplantation for Patients with Multiple Myeloma
Open the PDF for Total Marrow Irradiation: A New Ablative Regimen as Part of Tandem Autologous Stem Cell Transplantation for Patients with Multiple Myeloma in another window
Journal Articles

A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study

Thehang H. Luu, Robert J. Morgan, Lucille Leong, Dean Lim, Mark McNamara, Jana Portnow, Paul Frankel, David D. Smith, James H. Doroshow, David R. Gandara, Ana Aparicio, George Somlo, Carol Wong
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (21): 7138–7142.
https://doi.org/10.1158/1078-0432.CCR-08-0122
Published: 03 November 2008
View article titled, A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
Open the PDF for A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study in another window
Journal Articles

Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity

Robert J. Morgan, Jr., Timothy W. Synold, Bixin Xi, Dean Lim, Stephen Shibata, Kim Margolin, Roderich E. Schwarz, Lucille Leong, George Somlo, Przemyslaw Twardowski, Yun Yen, Warren Chow, Merry Tetef, Paul Lin, Benjamin Paz, Mariana Koczywas, Lawrence Wagman, David Chu, Paul Frankel, Susan Stalter, James H. Doroshow
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (4): 1232–1237.
https://doi.org/10.1158/1078-0432.CCR-06-1735
Published: 22 February 2007
View article titled, Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity
Open the PDF for Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity in another window
Journal Articles

The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial

Primo N. Lara, Jr, Philip C. Mack, Timothy Synold, Paul Frankel, Jeff Longmate, Paul H. Gumerlock, James H. Doroshow, David R. Gandara
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (12): 4444–4450.
https://doi.org/10.1158/1078-0432.CCR-04-2602
Published: 15 June 2005
View article titled, The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial
Open the PDF for The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial in another window
Journal Articles

Phase I Trial of Intraperitoneal Docetaxel in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity: Dose-Limiting Toxicity and Pharmacokinetics

Robert J. Morgan, Jr., James H. Doroshow, Timothy Synold, Dean Lim, Stephen Shibata, Kim Margolin, Roderich Schwarz, Lucille Leong, George Somlo, Przemyslaw Twardowski, Yun Yen, Warren Chow, Paul Lin, Benjamin Paz, David Chu, Paul Frankel, Susan Stalter
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5896–5901.
Published: 15 December 2003
View article titled, Phase I Trial of Intraperitoneal Docetaxel in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity: <subtitle>Dose-Limiting Toxicity and Pharmacokinetics</subtitle>
Open the PDF for Phase I Trial of Intraperitoneal Docetaxel in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity: <subtitle>Dose-Limiting Toxicity and Pharmacokinetics</subtitle> in another window
Journal Articles

SU5416 Plus Interferon α in Advanced Renal Cell Carcinoma: A Phase II California Cancer Consortium Study with Biological and Imaging Correlates of Angiogenesis Inhibition

Primo N. Lara, Jr., David I. Quinn, Kim Margolin, Frederick J. Meyers, Jeff Longmate, Paul Frankel, Philip C. Mack, Corinne Turrell, Peter Valk, Jyotsna Rao, Penelope Buckley, Ted Wun, Robert Gosselin, Irina Galvin, Paul H. Gumerlock, Heinz Josef Lenz, James H. Doroshow, David R. Gandara
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (13): 4772–4781.
Published: 27 October 2003
View article titled, SU5416 Plus Interferon α in Advanced Renal Cell Carcinoma: <subtitle>A Phase II California Cancer Consortium Study with Biological and Imaging Correlates of Angiogenesis Inhibition</subtitle>
Open the PDF for SU5416 Plus Interferon α in Advanced Renal Cell Carcinoma: <subtitle>A Phase II California Cancer Consortium Study with Biological and Imaging Correlates of Angiogenesis Inhibition</subtitle> in another window
Journal Articles

Tirapazamine Plus Carboplatin and Paclitaxel in Advanced Malignant Solid Tumors: A California Cancer Consortium Phase I and Molecular Correlative Study

Primo N. Lara, Jr., Paul Frankel, Philip C. Mack, Paul H. Gumerlock, Irina Galvin, Cynthia L. Martel, Jeff Longmate, James H. Doroshow, Heinz Josef Lenz, Derick H. M. Lau, David R. Gandara
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (12): 4356–4362.
Published: 10 October 2003
View article titled, Tirapazamine Plus Carboplatin and Paclitaxel in Advanced Malignant Solid Tumors: <subtitle>A California Cancer Consortium Phase I and Molecular Correlative Study</subtitle>
Open the PDF for Tirapazamine Plus Carboplatin and Paclitaxel in Advanced Malignant Solid Tumors: <subtitle>A California Cancer Consortium Phase I and Molecular Correlative Study</subtitle> in another window